VFVA - ETF AI Analysis
Top Page
Vanguard U.S. Value Factor ETF (VFVA)
Rating:69Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and in recent months, showing solid momentum.
Broad Sector Diversification
Holdings spread across financials, health care, consumer sectors, technology, energy, and more help reduce the impact of weakness in any single industry.
Low Expense Ratio
The fund’s relatively low ongoing fee means more of the ETF’s returns stay in investors’ pockets over time.
Negative Factors
Heavy U.S. Concentration
With almost all assets in U.S. companies, the fund offers limited diversification across global markets.
Mixed Top-Holding Performance
Some of the largest positions have shown weak or negative performance this year, which could drag on overall returns if the trend continues.
Significant Financial Sector Exposure
A large allocation to financial stocks means the ETF may be more sensitive to interest rate changes and stress in the banking sector.
VFVA vs. SPDR S&P 500 ETF (SPY)
AUM938.85M
RegionNorth America
Expense Ratio0.13%
Beta0.88
IssuerVanguard
Inception DateFeb 13, 2018
Dividend Yield1.78%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume13,551
30 Day Avg. Volume16,915
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
189.30Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering690
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VFVA Summary
Vanguard U.S. Value Factor ETF (VFVA) is a U.S.-focused fund that follows a “value” theme, aiming to invest in companies that appear cheap compared with their business fundamentals. It spreads your money across many sectors, including financials, health care, and technology. Well-known holdings include Salesforce and General Motors. Someone might invest in VFVA to tilt their portfolio toward value stocks, which can add diversification and potential long-term growth compared with broad market funds. A key risk is that value stocks can stay out of favor for long periods, so the ETF’s price can go up and down more than you expect.
How much will it cost me?The Vanguard U.S. Value Factor ETF (VFVA) has an expense ratio of 0.13%, meaning you’ll pay $1.30 per year for every $1,000 invested. This is lower than average because it is passively managed, focusing on a value-oriented strategy that keeps costs down while providing diversified exposure to undervalued stocks.
What would affect this ETF?The Vanguard U.S. Value Factor ETF (VFVA) could benefit from a strong U.S. economy, particularly if undervalued sectors like Financials, Health Care, and Consumer Cyclical experience growth. However, rising interest rates or economic slowdowns could negatively impact some of its top holdings, such as banks and consumer-focused companies, while regulatory changes in sectors like Health Care or Technology may also pose risks.
VFVA Top 10 Holdings
VFVA leans into classic U.S. value names, with health care and energy doing much of the heavy lifting lately. Bristol-Myers Squibb and Pfizer have been rising steadily, giving the fund a solid defensive backbone, while Newmont Mining’s strong run has added some shine from the materials side. Telecom giants Verizon and AT&T are more mixed, with Verizon pulling its weight and AT&T feeling a bit heavier in the portfolio. Salesforce and Comcast have been lagging, reminding investors that even value-focused funds can carry a few problem children. Overall, it’s a diversified, U.S.-only value play with no single sector dominating the story.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| EOG Resources | 0.85% | $8.07M | $76.02B | 22.95% | 78 Outperform | |
| Bristol-Myers Squibb | 0.83% | $7.84M | $129.92B | 37.81% | 78 Outperform | |
| Verizon | 0.79% | $7.54M | $206.74B | 10.67% | 81 Outperform | |
| AT&T | 0.78% | $7.44M | $177.20B | -13.05% | 71 Outperform | |
| Cigna | 0.75% | $7.12M | $74.11B | -5.44% | 72 Outperform | |
| Pfizer | 0.74% | $7.06M | $156.51B | 14.45% | 74 Outperform | |
| General Motors | 0.73% | $6.95M | $73.96B | 46.17% | 73 Outperform | |
| Salesforce | 0.72% | $6.83M | $206.19B | 2.56% | 80 Outperform | |
| Marathon Petroleum | 0.69% | $6.59M | $116.24B | 128.05% | 66 Neutral | |
| US Bancorp | 0.67% | $6.38M | $93.06B | 20.00% | 76 Outperform |
VFVA Technical Analysis
Neutral
―
Price Trends
158.74
Negative
151.96
Positive
144.11
Positive
Market Momentum
-0.32
Positive
37.82
Neutral
11.73
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VFVA, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 160.71, equal to the 50-day MA of 158.74, and equal to the 200-day MA of 144.11, indicating a neutral trend. The MACD of -0.32 indicates Positive momentum. The RSI at 37.82 is Neutral, neither overbought nor oversold. The STOCH value of 11.73 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for VFVA.
VFVA Peer Comparison
Comparison Results
Performance Comparison
VFVA
Vanguard U.S. Value Factor ETF
156.26
30.59
24.34%
LSVD
LSV Disciplined Value ETF
―
―
―
QVAL
Alpha Architect U.S. Quantitative Value ETF
―
―
―
AIVL
WisdomTree U.S. AI Enhanced Value Fund
―
―
―
BUSA
Brandes U.S. Value ETF
―
―
―
GVLU
Gotham 1000 Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents